Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection
Clinical trial NCT04824365 · COMPLETED
Trial details
- NCT number
- NCT04824365
- Sponsor
- Cellular Sciences, inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-12
- Primary completion
- 2022-08-12
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.